Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Alcohol Drinking 11Pancreatic Neoplasms 7Neoplasms 5Smoking Cessation 4Pancreatic Cyst 4Cancer Pain 4Agnosia 4Smoking 3Pain 3Depression 3Prostatic Neoplasms 2Postoperative Complications 2Neoplasms, Cystic, Mucinous, and Serous 2Multiple Endocrine Neoplasia Type 1 2Lymphoma, Follicular 2Lymphoma 2Leukemia 2Infections 2Head and Neck Neoplasms 2Condylomata Acuminata 2Colorectal Neoplasms 2Cardiovascular Diseases 2Alcoholism 2Wounds and Injuries 1Warts 1Waldenstrom Macroglobulinemia 1Visceral Pain 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Tuberculosis 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Ethanol × Clear all
NCT04553458 2020-09-17

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

Sohag University

Completed
407 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡